Furazolidone-based therapies for Helicobacter pylori infection: a pooled-data analysis

Angelo Zullo, Enzo Ierardi, Cesare Hassan, Vincenzo De Francesco

Research output: Contribution to journalArticle

27 Citations (Scopus)


Furazolidone-based therapies are used in developing countries to cure Helicobacter pylori infection due to its low cost. The low bacterial resistance toward furazolidone may render appealing the use of this drug even in developed countries. However, some relevant safety concerns do exist in using furazolidone.
Original languageEnglish
Pages (from-to)11-17
Number of pages7
JournalSaudi Journal of Gastroenterology
Publication statusPublished - 2012
Externally publishedYes


  • Anti-Infective Agents, Local
  • Drug Resistance, Bacterial
  • Drug Therapy, Combination
  • Furazolidone
  • Helicobacter Infections
  • Helicobacter pylori
  • Humans


Dive into the research topics of 'Furazolidone-based therapies for Helicobacter pylori infection: a pooled-data analysis'. Together they form a unique fingerprint.

Cite this